19 October 2016 2 Min Read
Aspen faces fine in Italy
The JSE-listed pharma group says it did not tell shareholders as the €5.2m fine is ‘immaterial’ in the broader Aspen context
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In